Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
91 pending office actions • 48 art units • 86 examiners • 0 of 91 (0%) have an AI response strategy ready • 72 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 30 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 30 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 7 (8%) |
| §103 only | 17 (19%) |
| §102 only | 3 (3%) |
| §112 only | 9 (10%) |
| Double-patenting only | 1 (1%) |
| Double-patenting + other | 10 (11%) |
| Multi-statute (no §101) | 44 (48%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NELSON, MICHAEL B | 2 | 21.2% | +37.0% |
| ALABI, OYELEYE A | 2 | 84.0% | +25.2% |
| DONOHUE, SEAN R | 2 | 41.4% | +21.0% |
| HERNANDEZ, JACKSON J | 2 | 51.4% | +45.0% |
| PARKIN, JEFFREY S | 2 | 63.7% | +21.7% |
| HOLMES, REX R | 1 | 80.2% | +17.9% |
| KWON, JOHN SEUNGJAI | 1 | 45.7% | +19.3% |
| VIJAYARAGHAVAN, JAGAMYA NMN | 1 | 62.5% | +49.3% |
| WOLLSCHLAGER, JEFFREY MICHAEL | 1 | 62.1% | +29.6% |
| GABR, MOHAMED GAMIL | 1 | 80.5% | +21.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17436023 | COMPOSITIONS OF MATTER WITH ACTIVITY TO REMOVE LIPOFUSCIN FROM RETINAL CELLS | BAKSHI, PANCHAM | 181d overdue |
| 17920475 | AN AUTOMATED CONTROLLED RELEASE DEVICE FOR LIVESTOCK MANAGEMENT AND METHODS OF USE THEREOF | KOHUTKA, BROOKE NICOLE | 87d overdue |
| 17064352 | INORGANIC NANOCAGES, AND METHODS OF MAKING AND USING SAME | ROGERS, JAMES WILLIAM | 70d overdue |
| 17973683 | MECHANICAL VACUUM DRESSING FOR MECHANICALLY MANAGING, PROTECTING AND SUCTIONING SMALL INCISIONAL WOUNDS | TRAN, NHU | 44d overdue |
| 17920931 | METHODS FOR DETECTING TISSUE DAMAGE, GRAFT VERSUS HOST DISEASE, AND INFECTIONS USING CELL-FREE DNA PROFILING | BAUSCH, SARAE L | 38d overdue |
| 18029596 | METHODS AND COMPOSITIONS FOR INCREASING UPTAKE, INTERNALIZATION, AND/OR RETENTION OF SMALL MOLECULE LIGANDS | DONOHUE, SEAN R | 36d overdue |
| 18006476 | CHELATION CROSSLINKED POLYMERS, METHODS OF MAKING SAME, AND USES THEREOF | NGUYEN, HA S | 35d overdue |
| 17969392 | FLUORINE-FREE OIL REPELLENT COATING, METHODS OF MAKING SAME, AND USES OF SAME | NELSON, MICHAEL B | 26d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18029596 | METHODS AND COMPOSITIONS FOR INCREASING UPTAKE, INTERNALIZATION, AND/OR RETENTION OF SMALL MOLECULE LIGANDS | DONOHUE, SEAN R | 36d overdue |
| 17969392 | FLUORINE-FREE OIL REPELLENT COATING, METHODS OF MAKING SAME, AND USES OF SAME | NELSON, MICHAEL B | 26d overdue |
| 18247427 | METHODS AND COMPOSITIONS FOR SYNERGISTIC UPTAKE AND RETENTION OF SMALL MOLECULE LIGANDS | DONOHUE, SEAN R | 11d overdue |
| 18020025 | THERAPEUTICALLY USEFUL CURE-PRO MOLECULES FOR E3 LIGASE MEDIATED DEGRADATION OF PROTEINS, AND METHODS OF MAKING AND USING THEM | HERNANDEZ, JACKSON J | 14d |
| 18020019 | THERAPEUTIC COMPOSITION OF CURE-PRO COMPOUNDS FOR TARGETED DEGRADATION OF BET DOMAIN PROTEINS, AND METHODS OF MAKING AND USAGE | HERNANDEZ, JACKSON J | 14d |
| 18877209 | INTRAVAGINAL DEVICE FOR TREATING PELVIC PAIN | HOLMES, REX R | — |
| 18865710 | PROTEIN PARTICLES INCLUDING AN ACTIVE AGENT AND METHODS OF MAKING AND USING THE SAME | KWON, JOHN SEUNGJAI | — |
| 18863977 | ADAPTATIONS FOR HIGH EFFICIENCY AND ALTERED PAM USAGE WITH TN7-CRISPR-CAS TRANSPOSITION SYSTEMS | VIJAYARAGHAVAN, JAGAMYA NMN | — |
| Art Unit | Apps |
|---|---|
| 1618 | 6 |
| 1671 | 3 |
| 1627 | 3 |
| 1672 | 2 |
| 1613 | 2 |
| 1631 | 2 |
| 1623 | 2 |
| 1799 | 2 |
| 3774 | 2 |
| 1629 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18877209 | INTRAVAGINAL DEVICE FOR TREATING PELVIC PAIN | HOLMES, REX R | — | §102§103 | Non-Final OA | — | Pending | Dec 19, 2024 |
| 18865710 | PROTEIN PARTICLES INCLUDING AN ACTIVE AGENT AND METHODS OF MAKING AND USING THE SAME | KWON, JOHN SEUNGJAI | — | §102§103§112DP | Non-Final OA | — | Pending | Nov 14, 2024 |
| 18863977 | ADAPTATIONS FOR HIGH EFFICIENCY AND ALTERED PAM USAGE WITH TN7-CRISPR-CAS TRANSPOSITION SYSTEMS | VIJAYARAGHAVAN, JAGAMYA NMN | — | §112 | Non-Final OA | — | Pending | Nov 07, 2024 |
| 18861012 | ACTIVE AND/OR INTELLIGENT PACKAGING MATERIALS CONTAINING RADICAL SCAVENGING LIGANDS | WOLLSCHLAGER, JEFFREY MICHAEL | — | §102§103 | Non-Final OA | — | Pending | Oct 28, 2024 |
| 18922685 | METHOD AND APPARATUS FOR PROVIDING INCREASED VISUALIZATION AND MANIPULATION OF A BODY SIDE WALL | GABR, MOHAMED GAMIL | 3771 | §102§103 | Non-Final OA | — | Pending | Oct 22, 2024 |
| 18919922 | ENHANCED DISEASE RESISTANCE IN PLANTS | BUI, PHUONG T | — | §102§112 | Non-Final OA | — | Pending | Oct 18, 2024 |
| 18911705 | NANOPARTICLE DRUG CONJUGATES | DICKINSON, PAUL W | — | §102§103§112DP | Non-Final OA | — | Pending | Oct 10, 2024 |
| 18908740 | ULTRASMALL NANOPARTICLES AND METHODS OF MAKING AND USING SAME | CABRAL, ROBERT S | — | §102§103 | Non-Final OA | — | Pending | Oct 07, 2024 |
| 18824827 | EXTRUSION OF AGRO-FOOD INDUSTRY BYPRODUCTS AND PROTEIN CONCENTRATES INTO VALUE-ADDED FOODS | WATTS, JENNA A | — | §102§103DP | Non-Final OA | — | Pending | Sep 04, 2024 |
| 18841883 | ENGINEERED IMMUNOMODULATORY ACCESSORY CELLS IMPROVE ALLOGENEIC ISLET TRANSPLANTATION WITHOUT IMMUNOSUPPRESSION | LARA, CAROLINE MONSERRAT | — | §102§103§112 | Non-Final OA | — | Pending | Aug 27, 2024 |
| 18779607 | MACROCYCLIC COMPLEXES OF ALPHA-EMITTING RADIONUCLIDES AND THEIR USE IN TARGETED RADIOTHERAPY OF CANCER | SAMALA, JAGADISHWAR RAO | — | DP | Non-Final OA | — | Pending | Jul 22, 2024 |
| 18726342 | COMBINATION THERAPIES INCLUDING PARP1 INHIBITORS | SHOWALTER, ALEXANDER KEITH | — | §103§112 | Non-Final OA | — | Pending | Jul 02, 2024 |
| 18757200 | IRE1 SMALL MOLECULE INHIBITORS | KIFLE, BRUCK | — | §112DP | Non-Final OA | — | Pending | Jun 27, 2024 |
| 18722792 | METHODS FOR ENHANCED NUCLEIC ACID DELIVERY | FALKOWITZ, ANNA R | 1600 | §103§112Other | Final Rejection | 10d overdue | Pending | Jun 21, 2024 |
| 18739113 | UFMYLATION INHIBITION TO TARGET TAUOPATHY IN HUMAN NEURONS | MARTIN, PAUL C | — | §102§103§112 | Non-Final OA | — | Pending | Jun 10, 2024 |
| 18716858 | METHODS AND COMPOSITIONS FOR GENETICALLY MODIFYING HUMAN GUT MICROBES | DHAR, MATASHA | — | §102§103§112 | Non-Final OA | — | Pending | Jun 05, 2024 |
| 18711287 | RNA SEQUENCES THAT INDUCE FLUORESCENCE OF SMALL MOLECULE FLUOROPHORES, MOLECULAR COMPLEXES, SENSORS, AND METHODS OF USE THEREOF | MOORE, JOHN DAVID | — | §102 | Non-Final OA | — | Pending | May 17, 2024 |
| 18696840 | NICOTINAMIDE RIBOSIDE TRIOLEATES CHLORIDE, COMPOSITIONS CONTAINING THIS COMPOUND, AND METHODS OF MAKING AND USING THIS COMPOUND | CRAIGO, BAHAR ALAWI | — | §112 | Non-Final OA | — | Pending | Mar 28, 2024 |
| 18687608 | COMPOSITIONS AND METHODS FOR CELL REPROGRAMMING | BARRON, SEAN C | 1653 | §102§103 | Non-Final OA | — | Pending | Feb 28, 2024 |
| 18686564 | MULTIVALENT VIRAL PARTICLES | GRIZER, CASSANDRA SENN | 1672 | §102§103 | Non-Final OA | — | Pending | Feb 26, 2024 |
| 18686146 | CONTAMINATION-FREE METAGENOMIC DNA SEQUENCING | HAQ, SHAFIQUL | — | §102§103 | Non-Final OA | — | Pending | Feb 23, 2024 |
| 18684335 | BROAD SPECTRUM ANTI-MICROBIAL POLYMERIC COMPOSITION | SHOMER, ISAAC | 1612 | §102§103Other | Non-Final OA | 14d | Pending | Feb 16, 2024 |
| 18436287 | COTTON LEAFROLL DWARF VIRUS-BINDING ANTIBODIES AND USES THEREOF | LY, KRISTINA ELISABETH | 1671 | §103§112 | Non-Final OA | — | Pending | Feb 08, 2024 |
| 18681728 | THERAPEUTIC COMPOSITIONS AND RELATED METHODS | SHIAO, YIH-HORNG | — | §102§103§112 | Non-Final OA | — | Pending | Feb 06, 2024 |
| 18433538 | METHODS OF CANCER TREATMENT VIA REGULATED FERROPTOSIS | WHEELER, THURMAN MICHAEL | 1619 | §102§103§112 | Non-Final OA | — | Pending | Feb 06, 2024 |
| 18293204 | POLYMER NANOPARTICLES VIA CONDENSED DROPLET POLYMERIZATION | STEVENS, MARK V | 1613 | §103§112 | Final Rejection | — | Pending | Jan 29, 2024 |
| 18420584 | IN-LINE ORAL DEVICE FOR SLEEP APNEA | MILLER, DANIEL A | 3786 | §102 | Non-Final OA | — | Pending | Jan 23, 2024 |
| 18563175 | CRISPR-CAS3 SYSTEMS FOR TARGETED GENOME ENGINEERING | NGUYEN, QUANG | 1631 | §102§103§112DP | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18562243 | APT1 and APT2 Inhibitors and Uses Thereof | CHENG, KAREN | 1623 | §102§112 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18561592 | CONTACTLESS ACOUSTOFLUIDIC SAMPLE AGITATOR AND USES THEREOF | SORKIN, DAVID L | 1799 | §102§103§112 | Non-Final OA | — | Pending | Nov 16, 2023 |
| 18560820 | EXTERNAL CRANIAL PROSTHESIS | SHARMA, YASHITA | 3774 | §102§103 | Non-Final OA | — | Pending | Nov 14, 2023 |
| 18559655 | INHIBITORS AND DEGRADERS OF PIP4K PROTEIN | GAUGER, PAUL RANDALL | 1629 | §112 | Non-Final OA | — | Pending | Nov 08, 2023 |
| 18557888 | HYDROPHOBIC AND OLEOPHOBIC COATINGS, METHODS OF MAKING SAME AND USES OF SAME | NELSON, MICHAEL B | 1787 | §103 | Final Rejection | — | Pending | Oct 27, 2023 |
| 18555184 | IMPLANTABLE CELL ENCAPSULATION SYSTEMS | HARRIS, WESLEY G | 3783 | §102§103§112 | Non-Final OA | — | Pending | Oct 12, 2023 |
| 18286315 | OPTICAL CLEARING AND AUTO-FLUORESCENCE QUENCHING SOLUTIONS AND METHOD OF USE FOR ENHANCED MICROSCOPY IMAGING OF BIOLOGICAL TISSUES | XU, QING | 1656 | §102§103§112DP | Non-Final OA | — | Pending | Oct 10, 2023 |
| 18285920 | A MULTIPLEX ASSAY FOR THE DIAGNOSIS OF BRUCELLA CANIS INFECTION | CHHAY, BONIRATH | 1645 | §103§112 | Non-Final OA | — | Pending | Oct 06, 2023 |
| 18552566 | ULTRATHIN POLYMER FILMS AS PROTECTIVE COATINGS FOR BATTERY ELECTRODES | BERNATZ, KEVIN M | 1785 | §102§112 | Non-Final OA | — | Pending | Sep 26, 2023 |
| 18551786 | ORAL DELIVERY OF SILICA/ALUMINOSILICATE NANOPARTICLES | WESTERBERG, NISSA M | 1618 | §103DP | Non-Final OA | — | Pending | Sep 21, 2023 |
| 18550622 | ANODES VIA INTERFACIAL BONDING, METHODS OF MAKING SAME, AND USES THEREOF | CHAU, LINDA N | 1785 | §102§103§112 | Non-Final OA | — | Pending | Sep 14, 2023 |
| 18281440 | METHODS FOR IMPROVING POULTRY HEALTH | SEITZ, ANTHONY JOSEPH | 1629 | §102§103§112 | Non-Final OA | — | Pending | Sep 11, 2023 |
| 18547725 | SYSTEMS AND METHODS FOR USING DEEP-LEARNING ALGORITHMS TO FACILITATE DECISION MAKING IN GYNECOLOGIC PRACTICE | TOKARCZYK, CHRISTOPHER B | 3687 | §103 | Non-Final OA | 28d | Pending | Aug 24, 2023 |
| 18277519 | Integrated Quantum Computing with Epitaxial Materials | PATERSON, BRIGITTE A | — | §102§112 | Non-Final OA | — | Pending | Aug 16, 2023 |
| 18262509 | POLY(CYCLIC ACETAL)S, METHODS OF MAKING SAME, AND USES THEREOF | SERGENT, RABON A | 1765 | §103 | Non-Final OA | — | Pending | Jul 21, 2023 |
| 18273678 | COMPOSITIONS AND METHODS FOR THE IDENTIFICATION OF COMPOUNDS THAT PROTECT AGAINST LIPOFUSCIN CYTOTOXICITY | COLEMAN, BRENDA LIBBY | 1624 | §102 | Final Rejection | — | Pending | Jul 21, 2023 |
| 18262053 | ARTEMISININ-PROTEASOME INHIBITOR CONJUGATES AND THEIR USE IN THE TREATMENT OF DISEASE | NESTOR, DONNA MICHELLE | 1627 | §103 | Final Rejection | 16d | Pending | Jul 19, 2023 |
| 18259105 | MULTI-VOLUME MICROCHAMBER-BASED MICROFLUIDIC PLATFORM AND USE THEREOF | ALABI, OYELEYE A | 1797 | §102§103 | Non-Final OA | — | Pending | Jun 23, 2023 |
| 18259101 | GRADIENT-BASED MICROFLUIDIC CIRCUIT, DEVICE, AND METHOD FOR PERFORMING AN ASSAY | ALABI, OYELEYE A | 1797 | §102§103 | Non-Final OA | — | Pending | Jun 23, 2023 |
| 18268472 | ZWITTERIONIC LIPID NANOPARTICLE COMPOSITIONS, AND METHODS OF USE | LIPPERT, JOHN WILLIAM | 1615 | §103§112 | Non-Final OA | — | Pending | Jun 20, 2023 |
| 18265796 | METHODS OF INDUCING AN IMMUNOMODULATORY TUMOR RESPONSE | KASAYAN, KATRIEL BARCELLANO | 1643 | §101§103§112 | Non-Final OA | — | Pending | Jun 07, 2023 |
| 18249938 | SOLUTION ELECTROWRITING | SPENCER, MAXIMILIAN TOBIAS | 3774 | §102§103 | Non-Final OA | 26d | Pending | Apr 20, 2023 |
| 18247427 | METHODS AND COMPOSITIONS FOR SYNERGISTIC UPTAKE AND RETENTION OF SMALL MOLECULE LIGANDS | DONOHUE, SEAN R | 1618 | §103§112Other | Final Rejection | 11d overdue | Pending | Mar 30, 2023 |
| 18029596 | METHODS AND COMPOSITIONS FOR INCREASING UPTAKE, INTERNALIZATION, AND/OR RETENTION OF SMALL MOLECULE LIGANDS | DONOHUE, SEAN R | 1618 | §103§112Other | Final Rejection | 36d overdue | Pending | Mar 30, 2023 |
| 18025279 | CHARGED SURFACTANT PARTICLES AND BRUSH POLYMERIC PARTICLES, METHODS OF MAKING SAME, AND USES THEREOF | HUHN, RICHARD A | 1763 | §103 | Non-Final OA | — | Pending | Mar 08, 2023 |
| 18020025 | THERAPEUTICALLY USEFUL CURE-PRO MOLECULES FOR E3 LIGASE MEDIATED DEGRADATION OF PROTEINS, AND METHODS OF MAKING AND USING THEM | HERNANDEZ, JACKSON J | 1627 | §103DP | Final Rejection | 14d | Pending | Feb 06, 2023 |
| 18020019 | THERAPEUTIC COMPOSITION OF CURE-PRO COMPOUNDS FOR TARGETED DEGRADATION OF BET DOMAIN PROTEINS, AND METHODS OF MAKING AND USAGE | HERNANDEZ, JACKSON J | 1627 | §103DP | Final Rejection | 14d | Pending | Feb 06, 2023 |
| 18105204 | TISSUE-ENGINEERED INTERVERTEBRAL DISC WITH LIVING CELLS | VAN BUREN, LAUREN K | 1638 | §103 | Final Rejection | — | Pending | Feb 02, 2023 |
| 18006476 | CHELATION CROSSLINKED POLYMERS, METHODS OF MAKING SAME, AND USES THEREOF | NGUYEN, HA S | 1766 | §102§112 | Final Rejection | 35d overdue | Pending | Jan 23, 2023 |
| 18017165 | METHODS FOR ASSESSING THE SEVERITY AND PROGRESSION OF SARS-COV2 INFECTIONS USING CELL-FREE DNA | PARKIN, JEFFREY S | 1671 | §112 | Non-Final OA | — | Pending | Jan 20, 2023 |
| 18060835 | DIELECTRIC THIN FILM COMPRISING PEROVSKITE MATERIAL, CAPACITOR INCLUDING THE DIELECTRIC THIN FILM, AND ELECTRONIC DEVICE INCLUDING THE CAPACITOR | MOJADDEDI, OMAR F | 2898 | §102§112 | Final Rejection | 6d | Pending | Dec 01, 2022 |
| 17923679 | FUNCTIONALIZED POLY(GLYCEROL SEBACATE)S AND USES THEREOF | CLARKE, TRENT R | 1651 | §102§103 | Final Rejection | — | Pending | Nov 07, 2022 |
| 17973683 | MECHANICAL VACUUM DRESSING FOR MECHANICALLY MANAGING, PROTECTING AND SUCTIONING SMALL INCISIONAL WOUNDS | TRAN, NHU | 3781 | §103§112 | Final Rejection | 44d overdue | Pending | Oct 26, 2022 |
| 17920931 | METHODS FOR DETECTING TISSUE DAMAGE, GRAFT VERSUS HOST DISEASE, AND INFECTIONS USING CELL-FREE DNA PROFILING | BAUSCH, SARAE L | 1699 | §101§103§112 | Final Rejection | 38d overdue | Pending | Oct 24, 2022 |
| 17920475 | AN AUTOMATED CONTROLLED RELEASE DEVICE FOR LIVESTOCK MANAGEMENT AND METHODS OF USE THEREOF | KOHUTKA, BROOKE NICOLE | 3791 | §103§112 | Final Rejection | 87d overdue | Pending | Oct 21, 2022 |
| 17969392 | FLUORINE-FREE OIL REPELLENT COATING, METHODS OF MAKING SAME, AND USES OF SAME | NELSON, MICHAEL B | 1787 | §103§112 | Non-Final OA | 26d overdue | Pending | Oct 19, 2022 |
| 17919650 | TARGETING THE PALMOTYLATION/DEPALMOTYLATION CYCLE TO TREAT INFLAMMATORY DISEASES | AULAKH, CHARANJIT | 1621 | §112 | Final Rejection | 56d overdue | Pending | Oct 18, 2022 |
| 17917058 | ASSAY TO DETECT VIRUS | SALVOZA, M FRANCO G | 1672 | §101§103§112 | Non-Final OA | 41d | Pending | Oct 05, 2022 |
| 17916215 | NANOFIBER-ENABLED ENCAPSULATION DEVICES AND USES THEREOF | BECKHARDT, LYNDSEY MARIE | 1613 | §103 | Final Rejection | 97d overdue | Pending | Sep 30, 2022 |
| 17906134 | COMPOSITIONS AND METHODS COMPRISING IMPROVED GUIDE RNAs | VANHORN, ABIGAIL LOUISE | 1636 | §101§112 | Final Rejection | 22d overdue | Pending | Sep 12, 2022 |
| 17897864 | SYSTEM AND METHOD FOR PELVIC FLOOR FEEDBACK AND NEUROMODULATION | FERNANDES, PATRICK M | 3791 | §103 | Final Rejection | — | Pending | Aug 29, 2022 |
| 17881713 | IMAGE ACQUISITION METHODS FOR SIMULTANEOUSLY DETECTING GENETIC REARRANGEMENT AND NUCLEAR MORPHOLOGY | SANFORD, DIANA PATRICIA | — | §101§103 | Non-Final OA | — | Pending | Aug 05, 2022 |
| 17760033 | COMPOSITIONS AND METHODS FOR RAPID RNA-ADENYLATION AND RNA SEQUENCING | SCHLOOP, ALLISON ELIZABETH | 1683 | §112 | Final Rejection | — | Pending | Aug 03, 2022 |
| 17832628 | SINGLE CELL WHOLE GENOME AMPLIFICATION VIA MICROPILLAR ARRAYS UNDER FLOW CONDITIONS | BOWERS, NATHAN ANDREW | 1799 | §103 | Final Rejection | 33d | Pending | Jun 04, 2022 |
| 17769255 | GENE THERAPY FOR ALZHEIMER'S DISEASE | TRAN, CHRISTINA L | 1637 | §112 | Final Rejection | 7d | Pending | Apr 14, 2022 |
| 17760652 | HUMAN MITOCHONDRIAL DNA SEQUENCING BY TARGETED AMPLIFICATION OF MULTIPLEX PROBES (MTDNA-STAMP) | BUCHANAN, BAILEY CHEYENNE | 1682 | §101§103§112 | Final Rejection | 22d overdue | Pending | Mar 15, 2022 |
| 17640327 | COMBINATION ANTIVIRAL THERAPY FOR MEASLES | PARKIN, JEFFREY S | 1671 | §103§112 | Non-Final OA | — | Pending | Mar 03, 2022 |
| 17671033 | DEVICES, PROCESSES, AND SYSTEMS FOR DETERMINATION OF NUCLEIC ACID SEQUENCE, EXPRESSION, COPY NUMBER, OR METHYLATION CHANGES USING COMBINED NUCLEASE, LIGASE, POLYMERASE, AND SEQUENCING REACTIONS | HERBERT, MADISON TAYLOR | 1758 | §103 | Non-Final OA | — | Pending | Feb 14, 2022 |
| 17632063 | TARGETED GENE THERAPY TO TREAT NEUROLOGICAL DISEASES | HUMPHRIES, NICHOLAS ADAM | 1631 | §102§103§112 | Non-Final OA | — | Pending | Feb 01, 2022 |
| 17579470 | Methods and kits for diagnosis of cancer and prediction of therapeutic value | CRAIG, KAILA ANGELIQUE | 1618 | §103 | Final Rejection | 78d overdue | Pending | Jan 19, 2022 |
| 17622634 | MODULATION OF DENDRITIC CELL FUNCTION BY THE PHOSPHOLIPID MESSENGER LPA | BENAVIDES, JENNIFER ANN | 1675 | §103 | Final Rejection | 33d | Pending | Dec 23, 2021 |
| 17554511 | INTEGRATED ELECTRONICS ON THE ALUMINUM NITRIDE PLATFORM | SHEKER, RHYS PONIENTE | 2813 | §103§112 | Final Rejection | 22d | Pending | Dec 17, 2021 |
| 17615382 | ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF CYSTATHIONINE BETA-SYNTHASE (CBS) ENZYME FOR TREATING CBS DEFICIENCY | LEVIN, JOEL D | 1633 | §103 | Non-Final OA | — | Pending | Nov 30, 2021 |
| 17608537 | MARKERS FOR IDENTIFYING AND QUANTIFYING OF NUCLEIC ACID SEQUENCE MUTATION, EXPRESSION, SPLICE VARIANT, TRANSLOCATION, COPY NUMBER, OR METHYLATION CHANGES | CHUNDURU, SURYAPRABHA | 1681 | §101§102 | Final Rejection | — | Pending | Nov 03, 2021 |
| 17440895 | METHODS FOR CONTROLLING PROSTAGLANDIN-MEDIATED BIOLOGICAL PROCESSES | CORNET, JEAN P | 1628 | §103§112DP | Final Rejection | 3d overdue | Pending | Sep 20, 2021 |
| 17436023 | COMPOSITIONS OF MATTER WITH ACTIVITY TO REMOVE LIPOFUSCIN FROM RETINAL CELLS | BAKSHI, PANCHAM | 1623 | §102§103§112 | Non-Final OA | 181d overdue | Pending | Sep 02, 2021 |
| 17414414 | INDUCING FAVORABLE EFFECTS ON TUMOR MICROENVIRONMENT VIA ADMINISTRATION OF NANOPARTICLE COMPOSITIONS | VU, JAKE MINH | 1618 | §103Other | Non-Final OA | — | Pending | Jun 16, 2021 |
| 17265387 | METHODS FOR REDUCING ABNORMAL SCAR FORMATION | GALSTER, SAMUEL LEONARD | 1693 | §112 | Non-Final OA | 97d overdue | Pending | Feb 02, 2021 |
| 17264752 | GENE THERAPY METHODS TO CONTROL ORGAN FUNCTION | WILSON, MICHAEL C | 1638 | §103 | Non-Final OA | 60d overdue | Pending | Jan 29, 2021 |
| 17064352 | INORGANIC NANOCAGES, AND METHODS OF MAKING AND USING SAME | ROGERS, JAMES WILLIAM | 1618 | §102§103 | Final Rejection | 70d overdue | Pending | Oct 06, 2020 |
| 16969164 | ASSAY FOR DETECTION OF ANDROGEN RECEPTOR VARIANTS | GREENE, CAROLYN LEE | 1681 | §112 | Final Rejection | — | Pending | Aug 11, 2020 |
| 16482420 | ENGINEERING BLOOD VESSEL CELLS FOR TRANSPLANTATION | SPENCE, JENNIFER SUZANNE | 1633 | §103 | Non-Final OA | — | Pending | Jul 31, 2019 |
| 16240472 | ADENO-ASSOCIATED VIRUS MEDIATED DELIVERY OF C1EI AS A THERAPY FOR ANGIOEDEMA | SINGH, ANOOP KUMAR | 1632 | §103 | Final Rejection | — | Pending | Jan 04, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial